lobbying_activities: 2034651

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2034651	d01ca295-0230-4c40-85a1-f61da72bf39e	Q3	THE SMITH-FREE GROUP, LLC	35800	UNIVERSAL CORPORATION	2017	third_quarter	TOB	Discussions involving FDA regulation of Nitrosonoronicotine FDA Proposed Rule, Clarification of When Products Made or Derived from Tobacco are Regulated as Drugs, Devices, or Combination Productions; Amendments to Regulations Regarding "Intended Uses" (All Sections of Full text) H.R. 1136 FDA Deeming Authority Clarification Act of 2017(All sections of full text)	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2017-10-19T13:55:19.950000-04:00